NCATS Drug Repurposing

The NIH's Drug Repurposing Initiative: Will It Be a Waste? - Science

NCATS will now be testing drugs that have been shelved by the pharmaceutical industry for other potential uses. The motivation for this is ...

Therapeutics for Rare and Neglected Diseases (TRND) Projects

Drug Repurposing Screening for Rare and Neglected Diseases. Why ... The Division of Preclinical Innovation has created the NCATS Pharmaceutical ...

Exploring NCATS In-House Biomedical Data for Evidence-based ...

AbstractDrug repurposing is a strategy for identifying new uses of approved or investigational drugs that are outside the scope of the original medical ...

Exploring NCATS in-house biomedical data for evidence-based ...

Abstract. Drug repurposing is a strategy for identifying new uses of approved or investigational drugs that are outside the scope of the original medical ...

Repurposing Off-Patent Drugs: Research & Regulatory Challenges ...

Repurposing Off-Patent Drugs: Research & Regulatory Challenges Workshop · Bobbie Ann Mount, Program Officer, NCATS, NIH · Christopher P.

NCATS on X: "The Repurposing Off-Patent Drugs: Research ...

The Repurposing Off-Patent Drugs: Research & Regulatory Challenges workshop is underway! The first panel of the morning discussed regulatory ...

NCATS Launches Drug Repurposing Project with Big Pharma ...

NCATS Launches Drug Repurposing Project with Big Pharma, Investigators ... The projects to re-assess these compounds will likely lean heavily on ...

Repurposing in the News - Google Sites

NIH-NCATS Related Repurposing · United States Government ... Highlight: Drug repurposing, also known as drug repositioning, is a drug ...

Exploring NCATS In-House Biomedical Data for Evidence-based ...

PDF | Drug repurposing is a strategy for identifying new uses of approved or investigational drugs that are outside the scope of the ...

An update on Drug Repurposing: Re-written saga of the drug's fate

NCATS, a component of National Institute of Health (NIH) in the United States of America (USA), launched a program “Discovery of New Therapeutic Uses for ...

Drug Repurposing Approaches Reveal HIV Drug Holds Promise ...

A collaborative research team from Duke University, the University of Florida and NCATS has shown that an existing antiviral drug used against ...

Drug repurposing: a systematic review on root causes, barriers and ...

A drug repurposing approach screening of the National Health Institute Clinical Collection identified Ebselen as a potential lithium mimetic [68] ...

CURE ID: - FDA

“The potential importance of new therapeutic opportunities from repurposing drugs ... in collaboration with FDA and NCATS/NIH called the CURE · Drug Repurposing ...

Drug repurposing: approaches, methods and considerations - Elsevier

Drug repurposing, also called drug repositioning or drug reprofiling, is the identification of new therapeutic uses for existing or investigational drugs.

ARPA-H awards AI-driven project to repurpose approved medications

... National Center for Advancing Translational Sciences, part of the National Institutes of Health. ... repurposing candidates across all drug ...

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic ...

The NCATS pharmaceutical collection (NPC) contains 2,678 compounds, covering drugs approved by US FDA and foreign health agencies in European Union, United ...

Open-source approaches for the repurposing of existing or failed ...

In May 2012, the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) initiative for drug ...

3 Enabling Tools and Technology | Drug Repurposing and ...

REPURPOSING AT NCATS. The Therapeutics for Rare and Neglected Diseases (TRND) program is a collaborative drug discovery and development research program, not ...

NCATS Seeks Applications to Repurpose Existing Drugs - LinkedIn

NCATS plans to commit an estimated $6 million to fund six to 10 awards to support partnerships between the pharmaceutical companies and the ...

Triune Synergy in Biomedical Research: Uniting Pharmaceutical ...

... NIH through the Drug Repurposing Project at NCATS. Abstract. The drug discovery process is long, expensive, and prone to failure. The average cost of ...